ID   LNCaP C4
AC   CVCL_4783
SY   LNCaP-C4; LNCaPC4; LNCaP subline C4; C4
DR   ATCC; CRL-3313
DR   BTO; BTO:0005868
DR   cancercelllines; CVCL_4783
DR   Wikidata; Q54902813
RX   PubMed=8169003;
RX   PubMed=12725112;
RX   PubMed=35502546;
WW   https://en.wikipedia.org/wiki/LNCaP
CC   Population: Caucasian.
CC   Characteristics: Derived from a tumor that developed in castrated nude mice injected with LNCaP cells.
CC   Doubling time: ~24-36 hours (ATCC=CRL-3313); 26.30 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): ATCC=CRL-3313
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 9,9.1,10.3
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 24
//
RX   PubMed=8169003; DOI=10.1002/ijc.2910570319;
RA   Wu H.-C., Hsieh J.-T., Gleave M.E., Brown N.M., Pathak S.,
RA   Chung L.W.K.;
RT   "Derivation of androgen-independent human LNCaP prostatic cancer cell
RT   sublines: role of bone stromal cells.";
RL   Int. J. Cancer 57:406-412(1994).
//
RX   PubMed=12725112; DOI=10.1385/1-59259-372-0:21;
RA   Russell P.J., Kingsley E.A.;
RT   "Human prostate cancer cell lines.";
RL   Methods Mol. Med. 81:21-39(2003).
//
RX   PubMed=35502546; DOI=10.1158/0008-5472.CAN-22-1065;
RA   Abate-Shen C., Nunes de Almeida F.;
RT   "Establishment of the LNCaP cell line -- the dawn of an era for
RT   prostate cancer research.";
RL   Cancer Res. 82:1689-1691(2022).
//